All Almirall articles
-
Business
AstraZeneca stocks respiratory and cancer pipelines
A $2bn deal with Almirall and a raft of acquisitions and partnership deals bulk up two focus areas for the company
A $2bn deal with Almirall and a raft of acquisitions and partnership deals bulk up two focus areas for the company